In 2023, the use of antiinfective medicines in South Korea stood at 32.8 units (Defined Daily Dosage) per thousand persons per day. Forecasted data indicates a consistent decline in the use of antiinfective medicines from 31.6 units in 2024 to 28.2 units in 2028. The year-on-year percentage changes reveal a decreasing trend: -3.16% in 2025, -2.94% in 2026, -2.69% in 2027, and -2.42% in 2028. Over the past two years, the trend has been a notable -3.66% reduction from 2023 to 2024, and the Compound Annual Growth Rate (CAGR) from 2024 to 2028 reflects an average yearly decrease of -2.84%.

Future trends to watch for:

Increasing emphasis on antimicrobial resistance and policies that may further reduce the prescribed use of antiinfective medicines.
Adoption of novel treatment modalities and improved healthcare protocols.
Potential influence of global health initiatives focused on antimicrobial stewardship.
Technological advancements in early infection detection and personalized medicine.
Changes in public health campaigns and patient awareness.